echoloc

Praxis Precision Medicines, Inc. Tech Stack

Clinical-stage biotech developing CNS therapies from genetic insights

Biotechnology Research Boston, MA 51–200 employees Public Company

Praxis is a public clinical-stage biopharmaceutical company focused on central nervous system disorders driven by excitation-inhibition imbalance. The hiring velocity is accelerating with 26 roles posted in the last 30 days — dominated by healthcare, data, and engineering talent — alongside active projects in product launch readiness, Salesforce CRM build-out, and pharmacovigilance infrastructure, signaling a company in transition from preclinical research into commercial operations.

Tech Stack 24 technologies

Core StackSalesforce Smartsheet Python Databricks Bitbucket AWS Snowflake Intune Azure AD Adobe Acrobat Veeva RIM Veeva Submissions Veeva Publishing Veeva LC-MS HPLC qPCR Paycom Azure Veeva Vault Veeva QMS macOS Azure Entra ID Microsoft Defender for Endpoint

What Praxis Precision Medicines, Inc. Is Building

Challenges

  • Launch readiness
  • Unmet patient needs
  • Patient recruitment challenges
  • Ensuring hipaa compliance
  • Scaling people capability
  • Scaling payroll infrastructure
  • Preparing for commercialization
  • Operational gaps in safety processes
  • Vendor oversight challenges
  • Database migrations

Active Projects

  • Product launch readiness
  • Post-launch adoption strategies
  • Market development strategy
  • Stand up core psp operations
  • Support salesforce crm build and systems integrations
  • Integrated oversight plan
  • User acceptance testing of the edc system
  • Implementing new safety tools
  • Database migrations
  • Strengthening u.s. pharmacovigilance footprint

Hiring Activity

Accelerating25 roles · 25 in 30d

Department

Healthcare
5
Data
3
Engineering
2
Finance
2
HR
2
Research
2
Sales
2
Support
2

Seniority

Senior
11
Director
5
Mid
5
Lead
3
Manager
2
Principal
1

Notable leadership hires: Sales Director, Trade Director

Company intelligence

Find more companies like Praxis Precision Medicines, Inc. by tech stack, pain points and active projects

Get started free

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines develops therapies for neurological disorders using two proprietary platforms: Cerebrum (small molecule) and Solidus (antisense oligonucleotide). The company's strategy centers on genetic insights into shared biological targets and circuits that drive disease across rare and more prevalent conditions. Headquartered in Boston and publicly traded, Praxis operates across clinical development, regulatory, and emerging commercial functions. Current operational focus spans product launch readiness, systems integrations (Veeva for regulatory, Salesforce for sales operations), and workforce scaling — with hiring activity extending into Brazil alongside the U.S. market.

HeadquartersBoston, MA
Company Size51–200 employees
Hiring MarketsUnited States, Brazil

Frequently Asked Questions

What is Praxis Precision Medicines developing?

Therapies for central nervous system disorders characterized by excitation-inhibition imbalance, using two platforms: Cerebrum (small molecules) and Solidus (antisense oligonucleotides). Focus is on both rare and more prevalent neurological conditions driven by shared genetic mutations.

What tech stack does Praxis use?

Regulatory: Veeva (RIM, Submissions, Publishing, Vault, QMS). CRM/operations: Salesforce, Smartsheet, Paycom. Data/analytics: Python, Databricks, Snowflake. Cloud: AWS, Azure. Lab analytics: LC-MS, HPLC, qPCR.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

How this profile is built

Praxis Precision Medicines, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.